CareDx(CDNA)
搜索文档
CareDx(CDNA) - 2020 Q3 - Earnings Call Transcript
2020-11-02 01:07
CareDx, Inc. (NASDAQ:CDNA) Q3 2020 Earnings Conference Call October 29, 2020 5:00 PM ET Company Participants Greg Chodaczek - Managing Director Peter Maag - Chairman and Chief Executive Officer Reginald Seeto - President and Chief Business Officer Michael Bell - Chief Financial Officer Conference Call Participants Brandon Couillard - Jefferies Steven Mah - Paper Sandler Alex Nowak - Craig-Hallum Capital Group Andrew Cooper - Raymond James Sung Ji Nam - BTIG Yi Chen - H.C. Wainwright Operator Greetings and w ...
CareDx(CDNA) - 2020 Q3 - Quarterly Report
2020-10-30 05:11
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-365 ...
CareDx(CDNA) - 2020 Q2 - Earnings Call Presentation
2020-08-08 04:00
| --- | --- | |----------------------------|-------| | | | | The Allo-Transplantation | | | | | | Company | | | Focused on better outcomes | | | through personalized | | | transplant surveillance | | August 2020 Allotransplant (allo- meaning "other" in Greek) is the transplantation of cells, tissues or organs to a recipient from a genetically non-identical donor of the same species el Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements. All statements ...
CareDx(CDNA) - 2020 Q2 - Earnings Call Transcript
2020-08-05 10:44
CareDx, Inc (NASDAQ:CDNA) Q2 2020 Earnings Conference Call August 4, 2020 4:30 PM ET Company Participants Greg Chodaczek - Head of Investor Relations Peter Maag - Chief Executive Officer Michael Bell - Chief Financial Officer Reginald Seeto - Chief Business Officer Conference Call Participants Brandon Couillard - Jefferies & Company, Inc. Rachel Vatnsdal - Piper Sandler Alexander Nowak - Craig-Hallum Capital Group LLC Andrew Cooper - Raymond James & Associates, Inc. Yi Chen - HC Wainwright Operator Greeting ...
CareDx(CDNA) - 2020 Q2 - Quarterly Report
2020-08-05 05:07
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36536 __ ...
CareDx (CDNA) Investor Presentation - Slideshow
2020-05-30 23:18
The Allo-Transplantation Company Focused on better outcomes through personalized transplant surveillance. May 2020 Allotransplant (allo- meaning "other" in Greek) is the transplantation of cells, tissues or organs to a recipient from a genetically non-identical donor of the same species Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements regar ...
CareDx(CDNA) - 2020 Q1 - Earnings Call Presentation
2020-05-02 02:08
The Transplant Company Focused on better outcomes through personalized transplant surveillance. April 2020 Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements regarding future financial position of CareDx, Inc. (together with its subsidiaries, "CareDx" or the "Company"), including financial targets, business strategy, and plans and objectives ...
CareDx(CDNA) - 2020 Q1 - Earnings Call Transcript
2020-05-01 10:55
CareDx, Inc (NASDAQ:CDNA) Q1 2020 Earnings Conference Call April 30, 2020 4:30 PM ET Company Participants Greg Chodaczek - Head of Investor Relations Peter Maag - Chief Executive Officer Michael Bell - Chief Financial Officer Reginald Seeto - Chief Business Officer Conference Call Participants Brandon Couillard - Jefferies & Company, Inc. Steven Mah - Piper Sandler Alexander Nowak - Craig-Hallum Capital Group LLC Andrew Cooper - Raymond James & Associates, Inc. Yi Chen - HC Wainwright Operator Good day and ...
CareDx(CDNA) - 2020 Q1 - Quarterly Report
2020-05-01 05:14
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36536 _ ...
CareDx Inc (CDNA) Investor Presentation - Slideshow
2020-03-06 03:12
The Transplant Company Focused on better outcomes through personalized transplant surveillance. February 27, 2020 Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements regarding future financial position of CareDx, Inc. (together with its subsidiaries, "CareDx" or the "Company"), including financial targets, business strategy, and plans and obje ...